Our work to date has pointed to a role for the 14-3-3θ isoform in neurodegenerative disorders marked by pathological aggregation of alpha-synuclein (αsyn), such as Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Here, SNCA is linked to Parkinson disease.